Unicycive Therapeutics, Inc. · NASDAQ:UNCY
Unicycive Therapeutics, Inc. shareholders
As of Sep 30, 2026, 92 institutions reported holding Unicycive Therapeutics, Inc., 39.1% of its shares. Largest: Vanguard, BlackRock and Nantahala Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Unicycive Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 1.5M | 5.1% | +105K | Nov 13, 2026 |
| BlackRock | 1.41M | 4.8% | −6,357 | Nov 13, 2026 |
| Nantahala Capital Management, LLC | 1.4M | 4.8% | −1.4M | Nov 13, 2026 |
| Geode Capital | 595K | 2.0% | +31,043 | Nov 6, 2026 |
| Millennium | 497K | 1.7% | +226K | Nov 16, 2026 |
| State Street | 480K | 1.6% | +29,434 | Nov 12, 2026 |
| Logos Global Management LP | 474K | 1.6% | no change | Nov 19, 2026 |
| Diametric Capital, LP | 404K | 1.4% | +30,029 | Nov 16, 2026 |
| Orbimed Advisors LLC | 387K | 1.3% | new | Nov 16, 2026 |
| Eversept Partners, LP | 336K | 1.2% | new | Nov 16, 2026 |